Venkat Nelabhotla

Venkat is a definitive growth catalyst and transformative CEO with a 35-year legacy of orchestrating multi-fold market capitalization and revenue growth across the biotechnology, pharmaceutical, and consumer goods sectors. A rare executive who blends elite strategic acumen with an entrepreneurial bias for action, he has consistently bridged the gap between cutting-edge scientific innovation and aggressive commercial execution.

His leadership footprint is defined by high-impact milestones:

The Biotech Visionary: As Co-Founder and CEO of Vyome Therapeutics, he successfully capitalized early-stage deep-tech, engineered a highly unique global product pipeline, and scaled the venture into an international biopharmaceutical player.
The Value Creator: At the helm of publicly listed Emami Ltd. and consumer giant CavinKare, he deployed aggressive brand-building and decisive M&A strategies to multiply enterprise market value and disrupt established industries.
The Scale Architect: His tenure at global pharma leaders Aurobindo and Shantha Biotechnics (Sanofi) cemented his reputation for launching complex biosimilars, shaping vaccine strategies, and unlocking massive top-line growth.

View this post on Instagram

Executive Profile: Venkat Nelabhotla

Co-Founder, President, CEO & Board Member, Vyome Holdings, Inc. & Vyome Therapeutics, Inc.

Alumnus, IIM Ahmedabad | Veteran Life Sciences & Consumer Growth Leader

Executive Summary

Venkat is a visionary senior executive, serial entrepreneur, and corporate strategist with over 35 years of exceptional leadership spanning the biotechnology, pharmaceuticals, and consumer products industries. Renowned for his ability to scale organizations from inception to global prominence, Venkat has consistently driven multi-fold market capitalization growth, engineered high-value M&A transactions, and commercialized disruptive product pipelines. As a leader, he seamlessly bridges the gap between scientific innovation and commercial execution, transforming early-stage ventures into resilient, institutionalized market leaders.

Core Competencies & Areas of Expertise

Corporate Scaling & Global Expansion: Proven track record of accelerating revenues and market cap multifold for both publicly traded and private enterprises.
Biotech & Pharma Innovation: Expert in advancing unique product pipelines, navigating clinical development, and driving biosimilar and vaccine strategies.
Venture Capital & Fund Raising: Adept at securing multi-stage venture financing, institutional investments, and strategic capital for deep-tech and life science ventures.
Mergers & Acquisitions (M&A): Deeply experienced in identifying strategic targets, corporate restructuring, and executing post-merger integration to unlock shareholder value.
Strategic Advisory & Governance: Active board member, angel investor, and ecosystem builder fostering the next generation of high-growth startups.

Professional Career & Leadership Milestones

Co-Founder, President, CEO & Board Member

Vyome Holdings, Inc. & Vyome Therapeutics, Inc. (2013 – Present)

Co-founded the company as Vyome Biosciences Private Limited in August 2013, steering its evolution into a premier global biopharmaceutical entity. Venkat has built a highly unique, intellectual property-led pipeline of products targeting hard-to-treat diseases and successfully raised substantial cross-border funding to fuel the company’s aggressive growth trajectory.

Chief Executive Officer & Executive Director

Emami Limited (NSE: EMAMILTD) (June 2007 – September 2010)

Led the executive management of this prominent, publicly listed fast-moving consumer goods and healthcare major. Venkat played a pivotal role in multiplying the company’s market capitalization through a holistic organizational transformation, aggressive market penetration, and high-impact M&A operations.

Senior Vice President

Aurobindo Pharma (NSE: AUROPHARMA) (June 2005 – June 2007)

Spearheaded strategic business units for one of India’s largest pharmaceutical companies, contributing to substantial top-line revenue growth and strengthening its international regulatory footprint.

Senior Executive & Strategic Leader

Shantha Biotechnics Private Limited (A Sanofi Company) (June 2002 – June 2005)

Drove commercialization and strategy at a pioneer in Indian biotechnology. Successfully launched critical biosimilar products into highly competitive markets and orchestrated the long-term developmental strategy for the company’s robust vaccine portfolio.

President

CavinKare Private Limited (September 1994 – June 2000)

Formulated and executed an aggressive growth strategy that resulted in a manyfold increase in corporate revenues. Engineered the successful launch of multiple iconic brands that disrupted the FMCG landscape and established CavinKare as a formidable market contender.

Board Appointments, Advisory Roles & Affiliations

Board Member & Strategic Advisor: Pulse Pharmaceuticals Private Limited
Ecosystem Enabler: Active Angel Investor supporting high-potential tech and life sciences startups.
Industry Thought Leader: Member, Confederation of Indian Industry (CII) National Biotech Forum.

Educational Credentials